109 -11 (73) 2024 - Ulmasova Sh.R., Musaev T.S. - FEATURES OF DIAGNOSIS, CLINIC AND CONSERVATIVE TREATMENT OF BRIDGE-LIKE ASEPTIC OSTEONECROSIS OF THE FEMORAL HEAD IN MILITARY PERSONNEL
FEATURES OF DIAGNOSIS, CLINIC AND CONSERVATIVE TREATMENT OF BRIDGE-LIKE ASEPTIC OSTEONECROSIS OF THE FEMORAL HEAD IN MILITARY PERSONNEL
Ulmasova Sh.R. - Central Military Hospital Uzbekistan
Musaev T.S. - Central Military Hospital Uzbekistan
Resume
This article presents clinical observations of four military personnel with bilateral osteonecrosis of the femoral heads after treatment with COVID-19. Prednisone doses in three patients were 4000 mg, 746 mg, and 533 mg. Corticosteroids were not used in one patient. Data showed that osteonecrosis in military personnel who underwent coronavirus developed in a shorter time compared with this pathology in patients without COVID-19. Two of four military personnel had a burdened family history (such as myocardial infarction, hypertension, and thrombosis). Hereditary vascular factors possibly played some roles in the genesis of the osteonecrosis of the femoral head in these military personnel. To understand the features of osteonecrosis development after COVID-19, further accumulation of evidence is necessary. Several synergistically influencing factors are important in the development of this disease after COVID-19.
Keywords: COVID-19, coronavirus infection, military personnel, corticosteroids, aseptic necrosis, osteonecrosis.
First page
635
Last page
639
For citation:Ulmasova Sh.R., Musaev T.S. - FEATURES OF DIAGNOSIS, CLINIC AND CONSERVATIVE TREATMENT OF BRIDGE-LIKE ASEPTIC OSTEONECROSIS OF THE FEMORAL HEAD IN MILITARY PERSONNEL//New Day in Medicine 11(73)2024 635-639 https://https://newdayworldmedicine.com/en/new_day_medicine/11-73-2024
List of References
- Han Q., Lin Q., Jin S., You L. Coronavirus 2019-nCoV: A brief perspective from the front line. //J Infect. 2020;80(4):373-377. doi: 10.1016/j.jinf.2020.02.010.
- Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. //N Engl J Med. 2020;382(8):727-733. doi: 10.1056/NEJMoa2001017.
- WHO coronavirus disease (COVID-19) Dashboard. Available from: https://covid19.who.int/.
- Mahase E. Covid-19: What do we know about «long covid»? //BMJ. 2020;370:m2815. doi: 10.1136/bmj.m2815.
- Leung T.Y.M., Chan A.Y.L., Chan E.W., Chan V.K.Y., Chui C.S.L., Cowling B.J. et al. Short- and potential long term adverse health outcomes of COVID-19: a rapid review. //Emerg Microbes Infect. 2020;9(1):2190-2199. doi: 10.1080/22221751.2020.1825914.
- Zhou B., Kojima S., Kawamoto A., Fukushima M. COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. //J Med Virol. 2021;93(5):2694-2704. doi: 10.1002/jmv.26754.
- Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S. et al. ‘Long-COVID’: a crosssectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalization for COVID-19. //Thorax. 2021;76(4):396-398. doi: 10.1136/thoraxjnl-2020-215818.
- Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. //J Med Virol. 2021;93(5):2555-2556. doi: 10.1002/jmv.26624.
- Avdeev S.N., Adamyan L.V., Alekseeva E.I., Bagnenko S.F., Baranov A.A., Baranova N.N. et al. [Temporary guidelines. Prevention, diagnosis and treatment of novel coronavirus infection (COVID-19)]. Version 10. 2021. (In Russian).
- Ye Z., Wang Y., Colunga-Lozano L.E., Prasad M., Tangamornsuksan W., Rochwerg B. et al. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. //CMAJ. 2020;192(27):E756-E767. doi: 10.1503/cmaj.200645.
- Powell C., Chang C., Naguwa S.M., Cheema G., Gershwin M.E. Steroid induced osteonecrosis: An analysis of steroid dosing risk. //Autoimmun Rev. 2010;9(11):721-743. doi: 10.1016/j.autrev.2010.06.007.
- Panin M.A., Zagorodniy N.V., Karchebnyi N.N., Sadkov I.A., Petrosyan A.S., Zakirova A.R. [Modern view on pathogenesis of non traumatic osteonecrosis]. Vestnik travmatologii i ortopedii im. N.N. Priorova [N.N. Priorov Journal of Traumatology and Orthopedics]. 2017;(2): 69-75. (In Russian).
- Ji H.L., Zhao R., Matalon S., Matthay M.A. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. //Physiol Rev. 2020;100(3):1065-1075. doi: 10.1152/physrev.00013.2020.
- Zhang P., Ju J., Han N., Jiang B. Reply to «Can femoral head necrosis induced by steroid therapy in patients infected with coronaviruses be reversed?». //Bone Res. 2021;9(1):2. doi: 10.1038/s41413-020-00133-x.
- Agarwala S.R., Vijayvargiya M., Pandey P. Avascular necrosis as a part of ‘long COVID-19’. //BMJ Case Rep. 2021;14(7):e242101. doi: 10.1136/bcr-2021-242101.
- Chan K.L., Mok C.C. Glucocorticoid-induced avascular bone necrosis: diagnosis and management. //Open Orthop J. 2012;6:449-457. doi: 10.2174/1874325001206010449.
- Wang A., Ren M., Wang J. The pathogenesis of steroidinduced osteonecrosis of the femoral head: A systematic review of the literature. //Gene. 2018;671:103-109. doi: 10.1016/j.gene.2018.05.091.
- Mont M.A., Pivec R., Banerjee S., Issa K., Elmallah R.K., Jones L.C. High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review. //J Arthroplasty. 2015;30(9): 1506-1512.e5. doi: 10.1016/j.arth.2015.03.036.
- Jones J.P., Koopman W.J. Osteonecrosis. In: Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2001. p. 2143-2164.
- Anderton J.M., Helm R. Multiple joint osteonecrosis following short-term steroid therapy. Case report. //J Bone Joint Surg Am. 1982;64(1):139-141.
file
download